Catherine Avery Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Catherine Avery Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.1K	Hold	12	–	–	0.01%	128
2026 Q2	$6.02K	Hold	12	–	–	﹤0.01%	132
2026 Q1	$5.9K	Hold	12	–	–	﹤0.01%	96
2025 Q4	$6.95K	Hold	12	–	–	﹤0.01%	108
2025 Q3	$5.82K	Hold	12	–	–	﹤0.01%	116
2025 Q2	$4.87K	Hold	12	–	–	﹤0.01%	121
2025 Q1	$5.97K	Hold	12	–	–	0.01%	112
2024 Q4	$6.24K	Buy	+12	New	+$6.6K	0.01%	107

Other funds holding TMO

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

GIA

Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.91B AUM 26.66% 1-Year Est. Return

CIPU

Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Catherine Avery Investment Management's TMO Position: Q3 2026 in Review

Catherine Avery Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 12 shares worth $8.1K. The position accounts for 0.01% of the portfolio, ranked #128.

Catherine Avery Investment Management first reported a position in TMO in Q4 2024 and has held it in 8 quarters since. 400 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Catherine Avery Investment Management held 12 shares of Thermo Fisher Scientific worth $8.1K as of Q3 2026.
Catherine Avery Investment Management left its Thermo Fisher Scientific share count unchanged in Q3 2026.
Thermo Fisher Scientific made up 0.01% of Catherine Avery Investment Management's portfolio in Q3 2026, its #128 holding.
Catherine Avery Investment Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 8 quarters since.
400 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Catherine Avery Investment Management's 13F filing for Q3 2026, filed 14 Oct 2026.